https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
- Forums
- ASX - By Stock
- If Viraleze 7 day treatment is competing with Paxlovid - who wins
https://www.cochranelibrary.com/web/cochrane/content?templateType...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.1¢ |
Change
0.001(1.11%) |
Mkt cap ! $37.49M |
Open | High | Low | Value | Volume |
9.1¢ | 9.3¢ | 8.9¢ | $196.0K | 2.178M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 164414 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 15150 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 164414 | 0.091 |
2 | 29795 | 0.090 |
2 | 117500 | 0.089 |
2 | 150000 | 0.088 |
1 | 11639 | 0.086 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 15150 | 1 |
0.096 | 30000 | 2 |
0.100 | 73848 | 3 |
0.105 | 375912 | 5 |
0.110 | 45099 | 6 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online